Renascience Inc. (4889.T)

JPY 278.0

(-0.71%)

Annual Cash Flows

(In JPY)
Breakdown 2024 2023 2022 2021 2020
Operating Cash Flow -230.51 Million -284.64 Million -230.49 Million -89.25 Million -178.31 Million
Net Income -256.37 Million -333.83 Million -253.08 Million -99.75 Million -184 Million
Depreciation & Amortization 1.83 Million 1.37 Million 3.07 Million 2.86 Million 3.04 Million
Deferred income taxes - - - - -
Stock-based compensation - - - - -
Change in working capital 21.42 Million 64.1 Million -17.44 Million 13.62 Million 3.35 Million
Other non-cash items 30 Thousand -15.1 Million 30.66 Million 10.73 Million 184 Million
Investing Cash Flow -1.56 Million 232 Thousand -296 Thousand -1.71 Million -380.69 Million
Investments in PPE -1.57 Million -2.22 Million -1.16 Million -1.01 Million -
Acquisitions - - - - -
Investment purchases - - - - -380.69 Million
Sales/Maturities of investments - - - - -
Other Investing Activities 10 Thousand 2.45 Million 868 Thousand -709 Thousand -
Financing Cash Flow 46.5 Million 110.37 Million 1.59 Billion 135.65 Million 380 Million
Debt repayment -46.5 Million -110.37 Million -276.42 Million -95.65 Million -380 Million
Dividends payments - - - - -
Common Stock Repurchased - - - - -
Common Stock Issuance - - 1.86 Billion 40 Million -
Other Financing Activities - - 1000.00 - -
Accounts receivables -4 Million - - - 601 Thousand
Accounts payables - - - - -
Inventory - - - - -
Other working capital 25.87 Million -18 Million 13 Million 7.89 Million 2.75 Million
Cash at beginning of period 1.83 Billion 2 Billion 644.94 Million 600.26 Million 779.27 Million
Cash at end of period 1.64 Billion 1.83 Billion 2 Billion 644.94 Million 600.26 Million
Capital Expenditure -1.57 Million -2.22 Million -1.16 Million -1.01 Million -
Effect of forex changes on cash - - - - -
Net cash flow / Change in cash -185.58 Million -174.03 Million 1.36 Billion 44.67 Million -179.01 Million
Free Cash Flow -232.09 Million -286.86 Million -231.65 Million -90.26 Million -178.31 Million

Cash Flow Charts